Global Bioenergies, Marc Delcourt is a former student of the Ecole Normale Supérieure, biology section. After completing a thesis in North America , it is towards R & D activities in the field of bioprocess and created in 1997 the first company in the field of industrial biology, Biométhodes. He left Biométhodes in 2008, then founded Global Bioenergies.
With degrees both in cell biology and in finance, François-Henri Reynaud contributed to the financing of many projects for innovative companies while working for several financial institutions. He led several operations in corporate finance (fundraisings, M&A) as a CFO for companies in the medical device and optoelectronics sectors. François-Henri Reynaud joined Global Bioenergies at the dawn of the industrial exploitation of its processes.
Frédéric Pâques has a PhD in Molecular Genetics (1994). After several years in academics in the US and in France, he served as Chief Scientific Officer of Cellectis for ten years. Frédéric Pâques is an expert in genetic engineering and protein engineering, and has authored 47 publications in peer-reviewed journals, and is inventor or co-inventor of several patents and patent applications. He joined Global Bioenergies in July 2013.
Following an MSc in Biotechnology and a biotech-focused Master’s in business administration, Thomas Buhl started his career in the technology transfer office of the C.E.A. He then became Business Development Manager at Biométhodes and subsequently took over the responsibility for the strategic development of MorphoSys, one of the three biggest German biotech companies. Thomas Buhl joined Global Bioenergies in October 2010.
Bernard CHAUD, Director of Industrial Strategy
After a career to date split between the chemicals industry (plant manager), the sugar industry (director of biofuels) and the French civil service (ministry of agriculture), Bernard Chaud joined Global Bioenergies in 2015 to oversee its Industrial Strategy.
Following a Ph.D. in biology at Imperial College London, Jean-Baptiste Barbaroux begun an academic career at King’s College London. His R&D activities first targeted the development of high throughput diagnostic tests before turning towards enzyme engineering. He joined Global Bioenergies in 2011 as a project leader in enzyme evolution before assuming the responsibility of Corporate Development in 2012.
Macha Anissimova obtained her PhD at the Université Technologique de Compiègne. She has since acquired unique expertise in enzymology and metabolic engineering in both public (CEA, Chemistry of Natural Substances Institute) and private establishments. Macha Anissimova joined Global Bioenergies in April 2009.